What is ZEOX's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.01B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for ZEOX?

P/E (TTM) is n/a and 52-week range is $0.97 to $2.99 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s ZEOX figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for ZEOX?

The company profile lists revenue (TTM) near $7M, net income (TTM) near $-393M, EPS (TTM) near $-0.59 when available from the market-data feed. Figures are informational and may lag live markets.

Where is ZEO ScientifiX Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Davie, Florida, US, 7.8M shares outstanding, ISIN US68621D2062 when available from company profile and filing metadata.

ZEO ScientifiX Inc

$ZEOX

Health Care · Biotechnology

IR Run Scenarios

$1.19

-1.25%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

ZEO ScientifiX, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of degenerative diseases. The company is headquartered in Davie, Florida and currently employs 20 full-time employees. The company went IPO on 2013-11-08. The firm is primarily focused on developing innovative biological therapeutics for regenerative medicine and the treatment of degenerative diseases. Its proprietary products, including Zofin, which are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles, and Patient Pure X (PPX), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient’s own peripheral blood (RAAM Products). Its RAAM Products and related services are principally used in the health care industry administered through doctors and clinics. The company has developed and begun to distribute additional products that incorporate its proprietary ingredients for products to be used in topical aesthetic applications and is actively exploring further development of additional products to be used in other topical aesthetic applications.

Employees

Website

www.zeoscientifix.com/

IPO

2013-11-08

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)